FDA Adds Genetic Metabolic Diseases Advisory Committee to List of Standing Committees

Summary

The Food and Drug Administration (FDA) is adding the Genetic Metabolic Diseases Advisory Committee (GeMDAC) to its list of standing committees, amending its advisory committee regulations.